BioTelemetry, Inc. (BEAT) News
Filter BEAT News Items
BEAT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BEAT News Highlights
- For BEAT, its 30 day story count is now at 4.
- Over the past 6 days, the trend for BEAT's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
Latest BEAT News From Around the Web
Below are the latest news stories about HEARTBEAM INC that investors may wish to consider to help them evaluate BEAT as an investment opportunity.
HeartBeam Bags New Patent for Heart Attack DetectionCardiac technology provider HeartBeam (NASDAQ:BEAT) has bagged a patent to detect heart attacks with its smartwatch-based monitor in the U.S. The development further builds up on BEAT’s 3D-vector electrocardiogram (VECG) platform and allows the company to make headways into the ischemia and Arrhythmia detection product lines BEAT estimates that the global wearables medical device market will reach $196 billion by 2030 and the new patent further enhances its capabilities. At the same time, the company is also focusing on furthering its HeartBeam AIMI and HeartBeam AIMIGo systems as well. Shares of the company have climbed nearly 170% over the past six months. |
HeartBeam Snags New Patent For 12-Lead ECG Smartwatch-Based Monitor To Detect Heart AttacksHeartBeam Inc (NASDAQ: BEAT) announced that its patent for a 12-lead electrocardiogram (ECG) smartwatch-based monitor intended to detect heart attacks and complex cardiac arrhythmias was allowed by the United States Patent and Trademark Office (USPTO). The company says that currently available wearables cannot provide a 12-lead ECG for heart attack detection, complex arrhythmia monitoring, or other cardiac disorders. HeartBeam's latest patent further expands on the company's anytime, anywhere ca |
New HeartBeam Patent for 12-Lead Electrocardiogram (ECG) Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac ArrhythmiasSANTA CLARA, Calif., November 16, 2022--New HeartBeam Patent for 12-Lead Electrocardiogram Smartwatch-based Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias |
HeartBeam Reports Third Quarter 2022 Financial ResultsSANTA CLARA, Calif., November 10, 2022--HeartBeam Reports Third Quarter 2022 Financial Results, Management to Host Webcast and Conference Call Today At 4:30 p.m. ET |
HeartBeam to Host Third Quarter 2022 Results Conference Call on Thursday November 10, 2022 at 4:30 p.m. Eastern TimeSANTA CLARA, Calif., October 25, 2022--HeartBeam to Host Third Quarter 2022 Results Conference Call on Thursday November 10, 2022 at 4:30 p.m. Eastern Time |
GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This WeekShort-squeeze stocks continue to be a big deal for speculative traders and we're helping them out with a list to keep in mind this week! |
HeartBeam to Present at LD Micro Main Event XV ConferenceSANTA CLARA, Calif., October 13, 2022--HeartBeam to Present at LD Micro Main Event XV Conference |
HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical OfficerSANTA CLARA, Calif., October 11, 2022--HeartBeam Names Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer |
HeartBeam to Bring 24/7 Heart Monitoring with Smartwatch Connectivity7 heart monitoring capability. Coupled with our breakthrough AIMIGo solution, we believe the overall HeartBeam system will bring a new and much higher level of diagnostic capability to cardiac patients. |
Stocks Edge Lower As Bond Yields RiseWall Street is taking a step back, as sentiment wanes and bond yields rise. |